GlassScriptPhysician profile
Kami Chandler
NPI 1316412158
$1,986.88
in general payments reported to CMS, 2019-2025
12 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $180 · 2022: $372 · 2023: $480 · 2024: $464 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,435.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,457.56 | 2021-2025 | Repatha, Repatha |
| Medtronic, INC. | $174.46 | 2024-2025 | Micra, Symplicity G3 |
| Novo Nordisk INC | $79.88 | 2023-2024 | Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $57.64 | 2024 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.29 | 2023-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $43.59 | 2023 | Xarelto |
| Recor Medical INC | $25.78 | 2024 | Paradise Renal Denervation System |
| Bayer Healthcare Pharmaceuticals INC. | $24.16 | 2025 | |
| Abbott Laboratories | $21.68 | 2023 | Cardiomems |
| Novartis Pharmaceuticals Corporation | $19.98 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $18.46 | 2024 | Arcalyst |
| Boston Scientific Corporation | $14.40 | 2023 | Watchman Access System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kami Chandler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.